by and among EPIMMUNE INC., HELENE PLOIX, as the Shareholder Representative, and theVoting Agreement • March 18th, 2005 • Epimmune Inc • Pharmaceutical preparations • Delaware
EPIMMUNE INC. SECURITIES PURCHASE AGREEMENT JULY 9, 2001Securities Purchase Agreement • November 14th, 2001 • Epimmune Inc • Pharmaceutical preparations • California
ARTICLE I DEFINITIONSLicense Agreement • November 14th, 2001 • Epimmune Inc • Pharmaceutical preparations • California
RECITALSEmployment Agreement • August 17th, 2005 • Idm Pharma, Inc. • Pharmaceutical preparations • California
BackgroundEscrow Agreement • May 17th, 1999 • Cytel Corp/De • Pharmaceutical preparations • Delaware
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 29th, 2001 • Epimmune Inc • Pharmaceutical preparations • California
RECITALS:Epimmune Inc • July 7th, 2005 • Pharmaceutical preparations • Delaware
RECITALS:Share Exchange Agreement • March 18th, 2005 • Epimmune Inc • Pharmaceutical preparations • Delaware
Rights Agreement Dated as of March 19, 1993Rights Agreement • April 5th, 2002 • Epimmune Inc • Pharmaceutical preparations • Delaware
SECOND AMENDMENT OF THE LICENSE AGREEMENT This Second Amendment (this "SECOND AMENDMENT") to the License Agreement is made and entered into as of March 15, 2004 by and between EPIMMUNE INC., having a principal place of business at 5820 Nancy Ridge...License Agreement • May 10th, 2004 • Epimmune Inc • Pharmaceutical preparations
EPIMMUNE INC.Epimmune Inc • April 13th, 2004 • Pharmaceutical preparations • California
ARTICLE 1 DEFINITIONSLicense Agreement • August 14th, 2003 • Epimmune Inc • Pharmaceutical preparations • California
EPIMMUNE INC.Epimmune Inc • September 19th, 2003 • Pharmaceutical preparations • California
EXHIBIT 10.3Investor Rights Agreement • July 16th, 1999 • Epimmune Inc • Pharmaceutical preparations • California
WITNESSETH:Agreement • April 5th, 2002 • Epimmune Inc • Pharmaceutical preparations • New York
EXHIBIT 10.50Collaboration Agreement • May 10th, 2004 • Epimmune Inc • Pharmaceutical preparations • California
RECITALS:Unit Purchase Agreement • April 13th, 2004 • Epimmune Inc • Pharmaceutical preparations • California
BY AND BETWEEN CYTEL CORPORATION/ EPIMMUNE INC. ANDEmployment Agreement • March 31st, 1998 • Cytel Corp/De • Pharmaceutical preparations • California
WITNESSETH:License Agreement • May 11th, 2001 • Epimmune Inc • Pharmaceutical preparations • California
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 21st, 2007 • Idm Pharma, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 20, 2007, among IDM Pharma, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
INDEMNITY AGREEMENTIndemnity Agreement • April 2nd, 2007 • Idm Pharma, Inc. • Pharmaceutical preparations • Delaware
This Agreement is made and entered into this ___ day of ___, ______ by and between IDM Pharma, Inc., a Delaware corporation (the “Corporation”), and ____________ (“Agent”).
ARTICLE 1 DEFINITIONSNon-Exclusive License Agreement • November 6th, 2002 • Epimmune Inc • Pharmaceutical preparations • California
RECITALSSeverance Benefits Agreement • August 16th, 1999 • Epimmune Inc • Pharmaceutical preparations • California
Exhibit 10.57 SERIES B PREFERRED STOCK PURCHASE AGREEMENT THIS SERIES B PREFERRED STOCK PURCHASE AGREEMENT (the "Stock Purchase Agreement") is made as of February 27, 1998 by and between G.D. Searle & Co., a Delaware corporation ("SEARLE"), and...Investor Rights Agreement • May 15th, 1998 • Cytel Corp/De • Pharmaceutical preparations • California
EXHIBIT 10.1 IDM PHARMA, INC. 2000 STOCK PLAN STOCK OPTION AGREEMENT (INCENTIVE AND NONSTATUTORY STOCK OPTIONS) Pursuant to your Stock Option Grant Notice ("Grant Notice") and this Stock Option Agreement, IDM Pharma, Inc. (the "Company") has granted...Stock Option Agreement • September 8th, 2005 • Idm Pharma, Inc. • Pharmaceutical preparations
Exhibit 2.2.4 FORM OF INDEMNITY ESCROW AGREEMENT ESCROW AGREEMENT, dated as of August 16, 2005 (this "Agreement"), among EPIMMUNE INC., a Delaware corporation (the "Issuer"), HELENE PLOIX (the "Shareholder Representative"), as designated...Indemnity Escrow Agreement • August 17th, 2005 • Idm Pharma, Inc. • Pharmaceutical preparations • Delaware
1 EXHIBIT 10.63 FIRST AMENDMENT TO LEASE (Nexus/Epimmune) THIS FIRST AMENDMENT TO LEASE (this "Amendment") is effective as of February 1, 1999, by and between NEXUS EQUITY VIII LLC, a California limited liability company, and EPIMMUNE INC., a Delaware...Lease • April 15th, 1999 • Cytel Corp/De • Pharmaceutical preparations
Exhibit 99.1 SHARE EXCHANGE AGREEMENTShare Exchange Agreement • March 18th, 2005 • Epimmune Inc • Pharmaceutical preparations • Delaware
EPIMMUNE INC. SHARE PURCHASE AGREEMENTShare Purchase Agreement • January 10th, 2002 • Epimmune Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.2 CYTEL CORPORATION PREFERRED STOCK EXCHANGE AGREEMENTPreferred Stock Exchange Agreement • July 16th, 1999 • Epimmune Inc • Pharmaceutical preparations • California
ANDEmployment Agreement • March 18th, 2005 • Epimmune Inc • Pharmaceutical preparations • California
Exhibit 10.82 STOCK PLEDGE AGREEMENT THIS STOCK PLEDGE AGREEMENT ("Pledge Agreement") is made by EMILE LORIA, an individual with a residence at 31 rue du Dr Jean Arlaud, 31500 Toulouse, France ("Pledgor"), in favor of EPIMMUNE INC., a Delaware...Stock Pledge Agreement • May 11th, 2001 • Epimmune Inc • Pharmaceutical preparations • California
ARTICLE 1 DEFINITIONSNon-Exclusive License Agreement • November 14th, 2001 • Epimmune Inc • Pharmaceutical preparations • California
EXHIBIT 10.3 IDM PHARMA, INC. 2000 STOCK PLAN FRENCH ANNEX STOCK OPTION AGREEMENT (QUALIFIED STOCK OPTIONS) Pursuant to your Stock Option Grant Notice ("Grant Notice") and this Stock Option Agreement, IDM Pharma, Inc. (the "Company") has granted you...Idm Pharma, Inc. • September 8th, 2005 • Pharmaceutical preparations
ContractEmployment Agreement • March 31st, 2009 • Idm Pharma, Inc. • Pharmaceutical preparations • California
This AMENDED & RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is effective as of December 11, 2008 (the “Effective Date”), by and between IDM Pharma Inc., a Delaware corporation (the “Company”), and Timothy C. Melkus (the “Executive”). This Agreement shall replace and supersede that certain Employment Agreement between Executive and the Company entered into effective as of December 3, 2007 (the “Prior Agreement”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party.”
